TET2 binds the androgen receptor and loss is associated with prostate cancer.
Oncogene
Nickerson, M L ML; Das, S S; Im, K M KM; Turan, S S; Berndt, S I SI; Li, H H; Lou, H H; Brodie, S A SA; Billaud, J N JN; Zhang, T T; Bouk, A J AJ; Butcher, D D; Wang, Z Z; Sun, L L; Misner, K K; Tan, W W; Esnakula, A A; Esposito, D D; Huang, W Y WY; Hoover, R N RN; Tucker, M A MA; Keller, J R JR; Boland, J J; Brown, K K; Anderson, S K SK; Moore, L E LE; Isaacs, W B WB; Chanock, S J SJ; Yeager, M M; Dean, M M; Andresson, T T
Somatic alterations contributing to metastasis of a castration-resistant prostate cancer.
Human Mutation
Nickerson, Michael L ML; Im, Kate M KM; Misner, Kevin J KJ; Tan, Wei W; Lou, Hong H; Gold, Bert B; Wells, David W DW; Bravo, Hector C HC; Fredrikson, Karin M KM; Harkins, Timothy T TT; Milos, Patrice P; Zbar, Berton B; Linehan, W Marston WM; Yeager, Meredith M; Andresson, Thorkell T; Dean, Michael M; Bova, G Steven GS